Related Experiment Video
Updated: Jun 27, 2026

Modeling Posthemorrhagic Hydrocephalus of Prematurity in Rats
Published on: March 28, 2025
[Relation between fresh plasma administration and morbidity in patients with HELLP syndrome]
Juana María Montoya Ramírez1, Ricardo Max Pacheco Cartagena, Raúl Cortés Flores
1Unidad de Cuidados Intensivos de Adultos, IMSS, Monterrey, NL, Mexico.
Introduction:
HELLP syndrome is a complication of severe preeclampsia; its incidence goes from 0.1 to 0.6% of pregnancies, and causes complications in 4% of patients.
Objective:
To evaluate frozen fresh plasma administration to prevent pregnancy complications in patients with HELLP syndrome.
Patients And Methods:
Retrospective, comparative and non-randomized study. Patients with HELLP syndrome were divided in two groups: first one (n=23) was treated with fresh frozen plasma (10 mL/kg/day), and second one (n=29) with dexamethasone. Complications, dialysis requirement, hospital stay, and mortality were compared (chi2 test was used).
Results:
Group 1 (n=23) had nine patients with HELLP syndrome type I, and 14 with type II. Group 2 (n=29) had 20 cases with HELLP syndrome type I, and nine with type II. Most frequent complication in group 1 was acute renal failure (22%), and hospital stay was 4.5 days. Group 2 had 13 patients with acute renal failure, three with pulmonary edema, one with cerebral edema, one with hepatic fracture, and one with placenta detachment. Hospital stay was from 8 to 30 days (p < 0.002). There were no maternal deaths in both groups.
Conclusions:
Fresh frozen plasma meaningfully reduces (43%) complications, hospital stay, and hemodialysis requirement (45%) in patients with HELLP syndrome.
Related Concept Videos
Hemodialysis II: Procedure and Complications
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test